May Thet Cho

A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers.

Milind Javle, John Bridgewater, Olumide B. Gbolahan et al. · Journal of Clinical Oncology · 2021 · 32 citations

Medicine, Oncology, Pharmacology +16

Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function

Jasmine C. Huynh, May Thet Cho, Edward Kim et al. · Therapeutic Advances in Medical Oncology · 2022 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly diagnosed metastatic colorectal cancer (GRANITE).

J. Randolph Hecht, Ardaman Shergill, Mark Gregory Goldstein et al. · Journal of Clinical Oncology · 2022 · 17 citations

Life Sciences, Immunology, Pharmacology +17

Post hoc analysis in patients (pts) with unresectable hepatocellular carcinoma (uHCC) who progressed to Child-Pugh B (CPB) liver function in the phase III REFLECT study of lenvatinib (LEN).

Jasmine Huynh, May Thet Cho, Edward Kim et al. · Journal of Clinical Oncology · 2021 · 13 citations

Medicine, Oncology, Pharmacotherapy +13